Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TPG Pace Beneficial Finance Corp. was a special purpose acquisition company (SPAC) formed by TPG in 2019 to pursue a business combination across various sectors. It raised $350 million in its October 2020 IPO. The company was not an operating healthcare entity but a vehicle for acquisitions and is no longer actively trading as an independent entity.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TPG Pace Beneficial Finance.